Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.69 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | PDE4A | P27815 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | TOP1 | P11387 | 1/20 | 0.32 |
| ▸ | MGAM | O43451 | 1/20 | 0.31 |
| ▸ | SI | P14410 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL521727 | 1.00 | LMNA (0.69) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL5133813 | 1.00 | LMNA (0.69) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL5051917 | 0.94 | LMNA (0.59) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL5028006 | 0.94 | LMNA (0.59) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL5052085 | 0.94 | LMNA (0.59) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL756618 | 0.94 | LMNA (0.59) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL20239655 | 0.87 | LMNA (0.44) | LMNAL3MBTL1TDP1ALDH1A1NR1I2 | |
| Mannitol SCHEMBL23066399 | 0.83 | LMNA (1.00) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| Mannitol SCHEMBL2477078 | 0.83 | LMNA (1.00) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| Mannitol SCHEMBL2297640 | 0.83 | LMNA (1.00) | LMNAL3MBTL1TDP1KDM4EPDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115066288-B | Method for coupling ligands to composite materials | 默克密理博有限公司 | 2025-03-11 | — | — | CN | claimed |
| US-20220410076-A1 | METHODS FOR COUPLING A LIGAND TO A COMPOSITE MATERIAL | MERCK MILLIPORE LTD. (IE) | 2022-12-29 | — | — | US | claimed |
| EP-4061515-A1 | METHODS FOR COUPLING A LIGAND TO A COMPOSITE MATERIAL | Merck Millipore Ltd. (IE) | 2022-09-28 | — | — | EP | claimed |
| CN-115066288-A | Method for coupling ligands to composite materials | 默克密理博有限公司 | 2022-09-16 | — | — | CN | claimed |
| US-20210161789-A1 | HETEROCYCLIC-DITHIOL CLICK CHEMISTRY | UNIV NORTHEASTERN (US) | 2021-06-03 | — | — | US | claimed |
| WO-2021099522-A1 | METHODS FOR COUPLING A LIGAND TO A COMPOSITE MATERIAL | MERCK MILLIPORE LTD. (IE) | 2021-05-27 | — | — | WO | claimed |
| EP-3778001-A1 | CHROMATOGRAPHY MEMBRANES FORMED BY THIOL-ENE OR THIOL-YNE CLICK POLYMERIZATION REACTIONS | Merck Millipore Ltd. (IE) | 2021-02-17 | — | — | EP | claimed |
| CN-111278508-A | Heterocyclic dithiol click chemistry | 东北大学 | 2020-06-12 | — | — | CN | claimed |
| EP-3259050-B1 | CHROMATOGRAPHY MEMBRANES FORMED BY THIOL-ENE OR THIOL-YNE CLICK POLYMERIZATION REACTIONS | MERCK MILLIPORE LTD (IE) | 2020-06-10 | — | — | EP | claimed |
| EP-3651854-A1 | HETEROCYCLIC-DITHIOL CLICK CHEMISTRY | Northeastern University (US) | 2020-05-20 | — | — | EP | claimed |
| CN-102058525-A | Lamivudine injection and preparation method thereof | Tianjin jinshi pharmaceutical co ltd | 2011-05-18 | — | — | CN | claimed |
| CN-102028653-A | Injection administration preparation containing lamivudine | TIANJIN PACIFIC PHARMACEUTICAL | 2011-04-27 | — | — | CN | claimed |
| CN-101756890-A | Parenteral preparation containing active entecavir and preparation method thereof | TIANJIN PACIFIC PHARMACEUTICAL | 2010-06-30 | — | — | CN | claimed |
| CN-101756891-A | Cladribine preparation administrated by injection and preparation method thereof | TIANJIN PACIFIC PHARMACEUTICAL | 2010-06-30 | — | — | CN | claimed |
| CN-101444478-A | Injection preparation containing active constituent adefovir dipivoxil and preparation method thereof | TIANJIN JINGUIGU XYLITOL CO LT (CN) | 2009-06-03 | — | — | CN | claimed |
| CN-101444490-A | Injection preparation containing anhydrogalactitol and preparation method thereof | TIANJIN JINGUIGU XYLITOL CO LT (CN) | 2009-06-03 | — | — | CN | claimed |
| CN-1299668-C | Nanometer realgar solid dispersion and its preparation method | UNIV HUAZHONG SCIENCE TECH (CN) | 2007-02-14 | — | — | CN | claimed |
| CN-1245975-C | Medicinal composition for stabilizing delotadine in preparation | TIANJIN MEDICINE ACADEMY (CN) | 2006-03-22 | — | — | CN | claimed |
| CN-1552324-A | Medicinal composition for stabilizing delotadine in preparation | 天津药物研究院 | 2004-12-08 | — | — | CN | claimed |
| CN-1478486-A | Nanometer realgar solid dispersion and its preparation method | 华中科技大学 | 2004-03-03 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210161789-A1 | HETEROCYCLIC-DITHIOL CLICK CHEMISTRY | TST, TMT1A, MTHFD2 | LMNA 4392/4885L3MBTL1 3408/4885TDP1 618/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.